Phase Ⅱ clinical study of gemcitablineplus etoposite in treatment of advanced non-small-cell carcinoma
- VernacularTitle:吉西他滨加依托泊苷方案治疗晚期非小细胞肺癌的Ⅱ期临床研究
- Author:
Li ZHANG
;
Zhongjun XIA
;
Yang ZHANG
- Publication Type:Journal Article
- Keywords:
non-small-cell carcinoma;
gemcitabine;
etopos ide;
cisplatin;
chemotherapy
- From:
China Oncology
1998;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05). The maj or toxicity included Neutropenia, nausea and vomiting. The severity of these sid e effects was mild to moderate and well tolerated. No severe toxicity was observ ed. Conclusions:Gemcitabine plus etoposide (GV) and Gencitabine plus cisplatin were both active regimen for advanced NSCLC, with high efficecy but talerated toxicity.
